Geneos Wealth Management Inc. - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q2 2022$107,000
+9.2%
10,0870.0%0.01%
+25.0%
Q1 2022$98,000
-33.3%
10,087
-1.9%
0.00%
-33.3%
Q4 2021$147,000
-16.9%
10,287
-0.5%
0.01%
-14.3%
Q3 2021$177,000
+4.1%
10,337
+23.9%
0.01%0.0%
Q2 2021$170,000
-20.9%
8,340
+3.1%
0.01%
+16.7%
Q1 2021$215,000
-61.6%
8,090
-60.9%
0.01%
-72.7%
Q4 2020$560,00020,7100.02%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$37,320,00092.58%
Gruss & Co., LLC 308,570$3,052,00026.27%
Founders Fund Growth Management, LLC 407,017$4,025,00011.55%
Belmont Capital, LLC 510,000$5,044,0005.95%
HARVARD MANAGEMENT CO INC 4,105,095$40,599,0005.05%
GUARDIAN CAPITAL ADVISORS LP 3,736,414$40,129,0005.01%
Intellectus Partners, LLC 1,091,505$10,795,0003.84%
ArchPoint Investors 617,213$6,104,0002.49%
BRANDYWINE MANAGERS, LLC 56,976$563,0001.85%
Casdin Capital, LLC 1,650,000$16,319,0001.07%
View complete list of ABCELLERA BIOLOGICS INC shareholders